We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Valeant Confirms Salix Is Up For Sale

Law360, New York (November 2, 2016, 2:59 PM EDT) -- Valeant Pharmaceuticals International Inc. on Tuesday confirmed that it’s looking to sell several of its assets, including gastrointestinal drugmaker Salix Pharmaceuticals Ltd., which it bought in 2015 for about $14.5 billion....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.